MARKET

ARKG

ARKG

ARK Genomic Revolution ETF
BATS

Real-time Quotes | Provided by Morningstar

56.15
+1.05
+1.91%
After Hours: 56.10 -0.05 -0.09% 19:04 07/07 EDT
OPEN
54.87
PREV CLOSE
55.10
HIGH
57.15
LOW
54.36
VOLUME
917.29K
TURNOVER
--
52 WEEK HIGH
57.15
52 WEEK LOW
24.00
TOTAL ASSET
1.38B
YTD YIELD
64.09%
1D
5D
1M
3M
1Y
5Y

ARKG News

More
ACADIA Pharmaceuticals: The Worst-Case Scenario For Investors
Seeking Alpha - Article · 06/08 00:01
ARK Invest CEO Cathie Wood doubles down on genomics, robots and 3D printing
Catherine Wood, the CEO and CIO of Ark Invest, details her strategies for her tech-focused, actively managed suite of exchange-traded funds. With CNBC's Bob Pisani.
CNBC.com · 05/18 18:55
ACADIA: The Company's Perspectives In Numbers.
Seeking Alpha - Article · 05/15 15:18
ARK Genomic Revolution Multi-Sector ETF: An Overbought But Promising Niche Play
Seeking Alpha - Article · 05/08 14:10
USO, OIL, TQQQ and SQQQ among weekly ETF movers
Seeking Alpha - Article · 04/18 03:51
Dems attack Trump over stalled efforts to lower drug prices
Seeking Alpha - Article · 02/21 14:32
Winning And Losing Industry Groups YTD
Seeking Alpha - Article · 02/06 11:09
Drugmakers getting creative over ways to pay for pricey meds
Seeking Alpha - Article · 01/13 17:16

Profile

Fund Name
ARK Genomic Revolution ETF
Risk
High Risk
Inception Date
2014-10-30
Benchmark
NASDAQ Health Care GR EUR*100.0%
Advisor Company
ARK ETF Trust
Custodian
The Bank of New York Mellon
Manager
Catherine Wood

Asset Allocation

515.53M
  • 99.7462%
  • 0.00%
  • 0.2538%
  • 0.00%

2020 Q1

515.53M

2019 Q4

503.65M

2019 Q3

396.32M

2019 Q2

448.72M

2019 Q1

393.50M

Dividend History

Ex-Div Date
Dividend Per Share
12/27/2019
1.0539
12/27/2018
0.1963
12/27/2017
0.1927